Lipella Pharmaceuticals Inc. SEC filings LIPO
Lipella Pharmaceuticals Inc. has 225 filings in SEC EDGAR's recent list, going back to Dec 9, 2005. Its latest annual report, Form 10-K, was filed on Mar 28, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2025, covering the quarter ended Sep 30, 2025. The most recent current report (Form 8-K) was filed on Jul 15, 2026 (bankruptcy). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 25-NSE | Delisting notice | Oct 6, 2025 | — |
| EFFECT | Filing | Apr 3, 2025 | — |
| CORRESP | Letter to the SEC | Apr 1, 2025 | — |
| D | Filing | Apr 1, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2025 | — |
| EFFECT | Filing | Jan 15, 2025 | — |
| CORRESP | Letter to the SEC | Jan 13, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2025 | — |
| D | Filing | Jan 7, 2025 | — |
| D | Filing | Aug 15, 2024 | — |
| EFFECT | Filing | Feb 8, 2024 | — |
| CORRESP | Letter to the SEC | Feb 6, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2024 | — |
| EFFECT | Filing | Nov 8, 2023 | — |
| D | Filing | Nov 7, 2023 | — |
| CORRESP | Letter to the SEC | Nov 6, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 6, 2023 | — |
| D | Filing | Sep 12, 2023 | — |
| POS EX | Filing | Apr 3, 2023 | — |
| CERT | Filing | Dec 20, 2022 | — |
| EFFECT | Filing | Dec 19, 2022 | — |
| 8-A12B | Filing | Dec 19, 2022 | — |
| CORRESP | Letter to the SEC | Dec 16, 2022 | — |
| CORRESP | Letter to the SEC | Dec 15, 2022 | — |
| CORRESP | Letter to the SEC | Dec 13, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 12, 2022 | — |
| CORRESP | Letter to the SEC | Dec 8, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 5, 2022 | — |
| CORRESP | Letter to the SEC | Nov 28, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 4, 2022 | — |
| CORRESP | Letter to the SEC | Oct 31, 2022 | — |
| CORRESP | Letter to the SEC | Oct 21, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 4, 2022 | — |
| CORRESP | Letter to the SEC | Jul 29, 2022 | — |
| UPLOAD | Letter from the SEC | May 2, 2022 | — |
| DRSLTR | Filing | Apr 20, 2022 | — |
| DRSLTR | Filing | Apr 20, 2022 | — |
| DRS/A | Filing | Apr 20, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 14, 2022 | — |
| DRSLTR | Filing | Feb 14, 2022 | — |
| DRS | Filing | Feb 14, 2022 | — |
| D/A | Filing | May 17, 2021 | — |
| D/A | Filing | Apr 12, 2021 | — |
| D | Filing | Nov 4, 2020 | — |
| D/A | Filing | Jan 27, 2011 | — |
| D/A | Filing | Jan 29, 2010 | — |
| D/A | Filing | Sep 29, 2009 | — |
| REGDEX/A | Auto-generated paper document | Sep 30, 2008 | — |
| REGDEX | Auto-generated paper document | Aug 8, 2008 | — |
| REGDEX | Auto-generated paper document | Jun 27, 2008 | — |
| REGDEX | Auto-generated paper document | May 8, 2008 | — |
| REGDEX/A | Auto-generated paper document | Feb 14, 2008 | — |
| REGDEX | Auto-generated paper document | Dec 19, 2006 | — |
| REGDEX | Auto-generated paper document | Dec 9, 2005 | — |
Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LIPO (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Pittsburgh, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1347242
- Former names
- LIPELLA PHARMACEUTICALS INC (until Sep 11, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.